• 1
    Marceau F, Lussier A, Regoli D, Giroud JP. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol 1983;14:209 229.
  • 2
    Rajakulasingam K, Polosa R, Church MK, Holgate ST, Howarth PH. Kinins and rhinitis. Clin Exp Allergy 1992;22:734 740.
  • 3
    Polosa R. Role of the kinin-kallikrein pathway in allergic diseases. Allergy 1993;48:217 225.
  • 4
    Greaves M & Shuster S. Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine. J Physiol 1967;193:255 267.
  • 5
    Crossman DC & Fuller RW. Bradykinin induced weal and flare is not mediated by histamine release or cyclooxygenase products. Br J Clin Pharmacol 1998;26:113 115.
  • 6
    Polosa R, Djukanovic R, Rajakulasingam K, Palermo F, Holgate ST. Skin responses to bradykinin, kallidin, and [desArg9]-bradykinin in nonatopic and atopic volunteers . J Allergy Clin Immunol 1993;92:683 688.
  • 7
    Li Kam Wa TC, Cooke ED, Turner P. Effects of selective histamine receptor antagonists on skin responses to intradermal bradykinin in healthy volunteers. J Pharm Pharmacol 1992;44:869 872.
  • 8
    Sansom JE, Brooks J, Burton JL, Archer CB. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin . Clin Exp Dermatol 1996;21:33 37.
  • 9
    Fadel R, David B, Herpin-richard N, Borgnon A, Rassemont R, Rihoux JP. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man . J Allergy Clin Immunol 1990;86:314 320.
  • 10
    Juhlin L & Pihl-lundin I. Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. Acta Derm Venereol 1992;72:197 200.
  • 11
    Burrows LJ, Skinner SP, Bewley AP, et al. Bradykinin induced wheal and flare in human skin in vivo is not mediated by histamine but is blocked by cetirizine. Allergy 1995;50 Suppl 26:76.
  • 12
    Rihoux J-P & Dupont P. Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl. Ann Allergy 1987;59:235 238.
  • 13
    Rihoux J-P, Ghys L, Coulie P. Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine. Ann Allergy 1990;65:139 142.
  • 14
    Van Neste D, Coussement C, Ghys L, Rihoux JP. Agonist-antagonist interactions in the skin: comparison of effects of loratadine and cetirizine on skin vascular responses to prick tests with histamine and substance P. J Dermatol Sci 1992;4:172 179.
  • 15
    Clough GF, Bennett AR, Church MK. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol 1998;138:806 814.
  • 16
    UCB file.
  • 17
    Lee PY & Pearce FL. Histamine secretion from mast cells stimulated with bradykinin. Agents Actions 1990;30:67 69.
  • 18
    Lawrence ID, Warner JA, Cohan VL, et al. Induction of histamine release from human skin mast cells by bradykinin analogs. Biochem Pharmacol 1989;38:227 233.
  • 19
    Hüther KJ, Renftle G, Barraud N, Burke JT, Koch-weser. Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol 1977;12:195 199.
  • 20
    Rosenzweig P, Caplain H, Chaufour S, Ulliac N, Cabanis MJ, Thebault JJ. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers. Br J Clin Pharmacol 1995;40:459 465.
  • 21
    Van Neste D & Rihoux JP. Inhibition of the cutaneous response to histamine by H1-blocking agents . Skin Pharmacol 1988;1:192 199.